These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 27500993

  • 21. Rupatadine relieves allergic rhinitis: a prospective observational study.
    Eloy P, Tobback L, Imschoot J.
    B-ENT; 2015; 11(1):11-8. PubMed ID: 26513942
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
    Okubo K, Suzuki T, Tanaka A, Aoki H.
    Allergol Int; 2019 Apr; 68(2):207-215. PubMed ID: 30391169
    [Abstract] [Full Text] [Related]

  • 23. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
    Saint-Martin F, Dumur JP, Pérez I, Izquierdo I, French Rupatadine-Rhinitis Study Group.
    J Investig Allergol Clin Immunol; 2004 Apr; 14(1):34-40. PubMed ID: 15160440
    [Abstract] [Full Text] [Related]

  • 24. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R, Ainsua-Enrich E, Torres-Atencio I, Martin M, Sánchez-Lopez J, Bartra J, Picado C, Mullol J, Valero A.
    J Investig Allergol Clin Immunol; 2017 Apr; 27(3):161-168. PubMed ID: 27758758
    [Abstract] [Full Text] [Related]

  • 25. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 26. Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis.
    Mion Ode G, Campos RA, Antila M, Rapoport PB, Rosario N, de Mello Junior JF, Guimarães RE, Mocellin M, Di Gesu G, Solé D, Wexler L, de Mello JF, Castro FM, Chavarria ML.
    Braz J Otorhinolaryngol; 2009 Jan; 75(5):673-9. PubMed ID: 19893935
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
    Katiyar S, Prakash S.
    Prim Care Respir J; 2009 Jun; 18(2):57-68. PubMed ID: 18695846
    [Abstract] [Full Text] [Related]

  • 28. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group.
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [Abstract] [Full Text] [Related]

  • 29. Safety evaluation of desloratadine in allergic rhinitis.
    González-Núñez V, Valero A, Mullol J.
    Expert Opin Drug Saf; 2013 May; 12(3):445-53. PubMed ID: 23574541
    [Abstract] [Full Text] [Related]

  • 30. Bepotastine besilate for the treatment of pruritus.
    Bielory L, Duttachoudhury S, McMunn A.
    Expert Opin Pharmacother; 2013 Dec; 14(18):2553-69. PubMed ID: 24191914
    [Abstract] [Full Text] [Related]

  • 31. Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I.
    J Biol Regul Homeost Agents; 2010 Dec; 24(2):177-83. PubMed ID: 20487631
    [Abstract] [Full Text] [Related]

  • 32. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
    Dakhale GN, Shinde AT, Mahatme MS, Hiware SK, Mishra DB, Mukhi JI, Salve AM.
    Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
    [Abstract] [Full Text] [Related]

  • 33. Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects.
    Shamizadeh S, Brockow K, Ring J.
    Allergo J Int; 2014 May; 23(3):87-95. PubMed ID: 26120520
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
    Church MK.
    Expert Opin Drug Saf; 2011 Sep; 10(5):779-93. PubMed ID: 21831011
    [Abstract] [Full Text] [Related]

  • 35. Cetirizine: a unique second-generation antihistamine for treatment of rhinitis and chronic urticaria.
    Pierson WE.
    Clin Ther; 1991 Sep; 13(1):92-9. PubMed ID: 1674232
    [Abstract] [Full Text] [Related]

  • 36. Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP, Sorkin EM, Goa KL.
    Drugs; 1989 Jan; 37(1):42-57. PubMed ID: 2523301
    [Abstract] [Full Text] [Related]

  • 37. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I, García-Lirio E, Soriano AM, Gamboa PM, Antépara I.
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [Abstract] [Full Text] [Related]

  • 38. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
    Van Cauwenberge P, De Belder T, Sys L.
    Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
    [Abstract] [Full Text] [Related]

  • 39. Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.
    Abajian M, Curto-Barredo L, Krause K, Santamaria E, Izquierdo I, Church MK, Maurer M, Giménez-Arnau A.
    Acta Derm Venereol; 2016 Jan; 96(1):56-9. PubMed ID: 26038847
    [Abstract] [Full Text] [Related]

  • 40. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R, Rahman J, Jaida J, Allala U, Palani A.
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.